Rees W D, Gibbons L C, Turnberg L A
Gut. 1983 Sep;24(9):784-9. doi: 10.1136/gut.24.9.784.
The effects of non-steroidal anti-inflammatory drugs and prostaglandins E(2) and F(2alpha) on the secretory and electrical activity of isolated rabbit fundic mucosa have been studied. Spontaneous acid secretion was inhibited by serosal side application of sodium thiocyanate (6x10(-2)M) and the resulting alkali secretion measured by pH stat tiration. Serosal side application of indomethacin (10(-5)M) or aspirin (3x10(-3)M) inhibited alkali secretion (0.55+/-0.06 to 0.12+/-0.06 mumol/cm(2)/h, n=6, p<0.01 and 0.28+/-0.06 to 0.11+/-0.03 mumol/cm(2)/h, n=7, p<0.02 respectively). Mucosal or serosal side prostaglandin E(2) (10(-5) to 10(-10)M) and F(2alpha) (10(-4) to 10(-10)M) failed to alter the rate of alkalinisation but secretion was significantly increased by serosal side 16,16-dimethyl-prostaglandin E(2) (10(-6)M) (0.90+/-0.20 to 1.50+/-0.30 mumol/cm(2)/h, n=6, p<0.01). Serosal side application of 10(-6)M prostaglandin E(2) to fundic mucosae pretreated with either aspirin (5x10(-3)M) or indomethacin (10(-5)M), to reduce endogenous E(2) formation, also failed to alter alkali secretion. Pretreatment of the mucosa with 16,16-dimethyl-E(2) (10(-6)M) abolished the inhibitory effect of indomethacin (10(-5)M) on alkali secretion (n=6) but did not modify the secretory response to aspirin (3x10(-3)M) (fall in alkali secretion with aspirin = 81+/-11% and with aspirin plus 16,16-dimethyl-E(2) = 72+/-10%, n=7). In the doses used, none of the prostaglandins or non-steroidal anti-inflammatory drugs altered transmucosal potential difference or electrical resistance. These results show that the damaging agents, aspirin and indomethacin, both inhibit gastric alkali secretion but that modes of action may differ. The observation that prostaglandins, E(2) and F(2alpha) failed to increase alkali production suggests that their protective activity against a variety of damaging agents as shown by others, may be mediated by another mechanism.
研究了非甾体抗炎药以及前列腺素E₂和F₂α对离体兔胃底黏膜分泌和电活动的影响。通过在浆膜侧应用硫氰酸钠(6×10⁻²M)抑制自发性胃酸分泌,并通过pH计滴定法测量由此产生的碱分泌。在浆膜侧应用吲哚美辛(10⁻⁵M)或阿司匹林(3×10⁻³M)可抑制碱分泌(分别从0.55±0.06降至0.12±0.06 μmol/cm²/h,n = 6,p<0.01;从0.28±0.06降至0.11±0.03 μmol/cm²/h,n = 7,p<0.02)。黏膜侧或浆膜侧应用前列腺素E₂(10⁻⁵至10⁻¹⁰M)和F₂α(10⁻⁴至10⁻¹⁰M)未能改变碱化速率,但浆膜侧应用16,16 - 二甲基前列腺素E₂(10⁻⁶M)可显著增加分泌(从0.90±0.20升至1.50±0.30 μmol/cm²/h,n = 6,p<0.01)。对用阿司匹林(5×10⁻³M)或吲哚美辛(10⁻⁵M)预处理以减少内源性E₂形成的胃底黏膜在浆膜侧应用10⁻⁶M前列腺素E₂,也未能改变碱分泌。用16,16 - 二甲基 - E₂(10⁻⁶M)预处理黏膜可消除吲哚美辛(10⁻⁵M)对碱分泌的抑制作用(n = 6),但未改变对阿司匹林(3×10⁻³M)的分泌反应(阿司匹林使碱分泌下降81±11%,阿司匹林加16,16 - 二甲基 - E₂使碱分泌下降72±10%,n = 7)。在所使用的剂量下,前列腺素或非甾体抗炎药均未改变跨黏膜电位差或电阻。这些结果表明,损伤性药物阿司匹林和吲哚美辛均抑制胃碱分泌,但作用方式可能不同。前列腺素E₂和F₂α未能增加碱产生的观察结果表明,它们对多种损伤性药物的保护活性,如其他人所表明的,可能由另一种机制介导。